Quoin Pharmaceuticals, Ltd. Analysis
| Analyst Ratings |
|
Average Target Price
|
12.00
|
|
Average Rating
|
4.50
|
|
# Strong Buys
|
2
|
|
# Buys
|
2
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2023-03-31
|
-0.56
|
0.00
|
0.56
|
100.00%
|
|
2022-12-31
|
-0.54
|
0.00
|
0.54
|
100.00%
|
|
2022-09-30
|
-1.35
|
-0.94
|
0.41
|
30.37%
|
|
2022-06-30
|
-3.08
|
-3.24
|
-0.16
|
-5.19%
|
|
2022-03-31
|
-8.81
|
-2.50
|
6.31
|
71.62%
|
|
2021-12-31
|
-0.74
|
-2.06
|
-1.33
|
-180.27%
|
|
2021-09-30
|
-3.25
|
-4.96
|
-1.71
|
-52.62%
|
|
2021-06-30
|
0.00
|
-0.18
|
0.00
|
0.00%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-6.68
|
|
2021-12-31
|
-8.95
|
|
2020-12-31
|
-0.10
|
|
2019-12-31
|
-6.91
|
|
2018-12-31
|
-17.17
|
|
2017-12-31
|
-18.55
|
|
2016-12-31
|
-10.17
|